<DOC>
	<DOC>NCT00898755</DOC>
	<brief_summary>RATIONALE: Collecting and storing samples of tissue, blood, and bone marrow from patients with cancer to study in the laboratory may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer. PURPOSE: This laboratory study is collecting and storing tissue, blood, and bone marrow samples from young patients with cancer.</brief_summary>
	<brief_title>Collecting and Storing Tissue From Young Patients With Cancer</brief_title>
	<detailed_description>OBJECTIVES: - Establish and bank cell lines and/or xenografts from pediatric patients with cancer. - Establish continuous cell lines, under carefully controlled conditions, from pediatric patients with cancer. - Establish transplantable xenografts in immunocompromised mice from tumor cells that are difficult to establish as continuous cell lines in vitro. - Create a bank of cell lines and generate sufficient vials of cryopreserved cells for distribution to investigators with approved COG biology protocols. - Characterize cell lines from childhood cancers with respect to DNA short tandem repeat molecular profile as a "fingerprint" of original cell line identity. - Characterize cell lines for the ability for sustained growth in tissue culture and/or as mouse xenografts. - Characterize cell lines for mycoplasma contamination. - Characterize cell lines for expression of molecular makers that confirm the tumor-type of the cell line and the immortal nature of the cells (telomerase) and the expression of molecular markers that may correlate with drug resistance. OUTLINE: This is a multicenter study. Specimens are stratified according to disease (acute lymphoblastic leukemia vs acute myeloid leukemia vs lymphoma vs osteogenic sarcoma vs Ewing family of tumors vs rhabdomyosarcoma vs primitive neuroectodermal tumor vs glioma vs astrocytoma vs rhabdoid tumors vs hepatoblastoma vs retinoblastoma vs Wilms tumor vs germ cell tumors vs other diagnoses). Leftover tissue from diagnostic procedures and/or surgery is cryopreserved and banked. Blood and/or bone marrow are also collected and banked. Cell lines are established and characterized via reverse-transcriptase polymerase chain reaction and/or flow cytometry for biomarkers and by DNA fingerprinting. Markers to be identified may include the following: - Neuroblastoma: tyrosine hydroxylase, protein gene product (PGP) 9.5, GD2, HLA class I, and HSAN 1.2 antigens - Ewing family of tumors: EWS-FLI1, EWS-ERG, and PGP 9.5 - Retinoblastoma: interphotoreceptor retinoid-binding protein - Acute lymphoblastic leukemia: immunophenotype - Alveolar rhabdomyosarcoma: PAX3-FKHR, PAX7-FKHR, and MyoD1 - All cell types: telomerase expression including hTR and hTERT Mutations of TP53 gene are detected by flow cytometry and/or immunocytochemistry. No results of these tests are provided to the patient, the patient's physician, or the patient's medical records. PROJECTED ACCRUAL: A total of 500 specimens per stratum will be accrued for this study.</detailed_description>
	<criteria>DISEASE CHARACTERISTICS: All malignant tissues from childhood cancers allowed including the following: Brain tumors (all types) Tissue should be submitted to CNS Committee Resource labs to be forwarded for this study, unless instructed otherwise on the COG web site Ewing family of tumors Rhabdomyosarcomas Other soft tissue sarcomas Osteogenic sarcomas Rhabdoid tumors Neuroblastomas Viable material for cell culture for neuroblastoma is collected via COGANBL00B1 and should not be submitted via this study unless the patient cannot be enrolled on COGANBL00B1* NOTE: *The same applies to any similar biology studies from other disease committees Retinoblastomas Anaplastic Wilms tumor Germ cell tumors Leukemias/lymphomas Acute myeloid leukemia (AML) Blood samples and bone marrow samples from patients at second relapse and beyond may be submitted for this study Bone marrow samples at diagnosis or first relapse must be submitted to an AML resource lab and will be forwarded for this study at the discretion of the AML Committee Acute lymphoblastic leukemia (ALL) Blood samples may be submitted directly to this study Bone marrow samples must be submitted to an ALL resource lab and will be forwarded for this study at the discretion of the ALL Committee Enrolled on a COG therapeutic, biology, or tissue banking protocol that allows collection of tissue for research and submission to a COGdesignated resource laboratory Participation in this protocol is not permitted until after tissue requirements for any active COG diseasespecific therapeutic, biology, or banking protocols have been satisfied Material may only be submitted for this protocol if tissue is available in excess of that required for satisfying active diseasespecific therapeutic and biological protocols Patients with diagnosis pending are eligible PATIENT CHARACTERISTICS: Not specified PRIOR CONCURRENT THERAPY: Not specified</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>childhood acute lymphoblastic leukemia in remission</keyword>
	<keyword>unspecified childhood solid tumor, protocol specific</keyword>
	<keyword>childhood acute myeloid leukemia in remission</keyword>
	<keyword>childhood central nervous system germ cell tumor</keyword>
	<keyword>childhood choroid plexus tumor</keyword>
	<keyword>childhood chronic myelogenous leukemia</keyword>
	<keyword>childhood craniopharyngioma</keyword>
	<keyword>childhood diffuse large cell lymphoma</keyword>
	<keyword>childhood extragonadal germ cell tumor</keyword>
	<keyword>childhood grade III lymphomatoid granulomatosis</keyword>
	<keyword>childhood infratentorial ependymoma</keyword>
	<keyword>childhood teratoma</keyword>
	<keyword>childhood grade I meningioma</keyword>
	<keyword>childhood grade II meningioma</keyword>
	<keyword>childhood grade III meningioma</keyword>
	<keyword>childhood supratentorial ependymoma</keyword>
	<keyword>childhood high-grade cerebral astrocytoma</keyword>
	<keyword>childhood low-grade cerebral astrocytoma</keyword>
	<keyword>metastatic childhood soft tissue sarcoma</keyword>
	<keyword>newly diagnosed childhood ependymoma</keyword>
	<keyword>nonmetastatic childhood soft tissue sarcoma</keyword>
	<keyword>previously treated childhood rhabdomyosarcoma</keyword>
	<keyword>previously untreated childhood rhabdomyosarcoma</keyword>
	<keyword>recurrent childhood acute lymphoblastic leukemia</keyword>
	<keyword>recurrent childhood acute myeloid leukemia</keyword>
	<keyword>recurrent childhood brain stem glioma</keyword>
	<keyword>recurrent childhood cerebellar astrocytoma</keyword>
	<keyword>recurrent childhood cerebral astrocytoma</keyword>
	<keyword>recurrent childhood ependymoma</keyword>
	<keyword>recurrent childhood grade III lymphomatoid granulomatosis</keyword>
	<keyword>recurrent childhood large cell lymphoma</keyword>
	<keyword>recurrent childhood lymphoblastic lymphoma</keyword>
	<keyword>recurrent childhood malignant germ cell tumor</keyword>
	<keyword>recurrent childhood medulloblastoma</keyword>
	<keyword>recurrent childhood rhabdomyosarcoma</keyword>
	<keyword>recurrent childhood small noncleaved cell lymphoma</keyword>
	<keyword>recurrent childhood soft tissue sarcoma</keyword>
	<keyword>recurrent childhood supratentorial primitive neuroectodermal tumor</keyword>
	<keyword>recurrent childhood visual pathway and hypothalamic glioma</keyword>
	<keyword>recurrent Wilms tumor and other childhood kidney tumors</keyword>
	<keyword>recurrent/refractory childhood Hodgkin lymphoma</keyword>
	<keyword>stage I childhood Hodgkin lymphoma</keyword>
	<keyword>stage I childhood large cell lymphoma</keyword>
	<keyword>stage I childhood liver cancer</keyword>
	<keyword>stage I childhood lymphoblastic lymphoma</keyword>
	<keyword>stage I childhood small noncleaved cell lymphoma</keyword>
	<keyword>stage II childhood Hodgkin lymphoma</keyword>
	<keyword>stage II childhood large cell lymphoma</keyword>
	<keyword>stage II childhood lymphoblastic lymphoma</keyword>
	<keyword>stage II childhood small noncleaved cell lymphoma</keyword>
	<keyword>stage III childhood Hodgkin lymphoma</keyword>
	<keyword>stage III childhood large cell lymphoma</keyword>
	<keyword>stage III childhood lymphoblastic lymphoma</keyword>
	<keyword>stage III childhood small noncleaved cell lymphoma</keyword>
	<keyword>stage IV childhood Hodgkin lymphoma</keyword>
	<keyword>stage IV childhood large cell lymphoma</keyword>
	<keyword>stage IV childhood lymphoblastic lymphoma</keyword>
	<keyword>stage IV childhood small noncleaved cell lymphoma</keyword>
	<keyword>untreated childhood acute lymphoblastic leukemia</keyword>
	<keyword>untreated childhood acute myeloid leukemia and other myeloid malignancies</keyword>
	<keyword>untreated childhood brain stem glioma</keyword>
	<keyword>untreated childhood cerebellar astrocytoma</keyword>
	<keyword>untreated childhood medulloblastoma</keyword>
	<keyword>untreated childhood supratentorial primitive neuroectodermal tumor</keyword>
	<keyword>untreated childhood visual pathway and hypothalamic glioma</keyword>
	<keyword>childhood hepatoblastoma</keyword>
	<keyword>extraosseous Ewing sarcoma/peripheral primitive neuroectodermal tumor</keyword>
	<keyword>localized Ewing sarcoma/peripheral primitive neuroectodermal tumor</keyword>
	<keyword>metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor</keyword>
	<keyword>recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor</keyword>
	<keyword>childhood hepatocellular carcinoma</keyword>
	<keyword>childhood immunoblastic large cell lymphoma</keyword>
	<keyword>childhood malignant ovarian germ cell tumor</keyword>
	<keyword>childhood malignant testicular germ cell tumor</keyword>
	<keyword>childhood Langerhans cell histiocytosis</keyword>
	<keyword>alveolar childhood rhabdomyosarcoma</keyword>
	<keyword>childhood Burkitt lymphoma</keyword>
	<keyword>de novo myelodysplastic syndromes</keyword>
	<keyword>previously treated myelodysplastic syndromes</keyword>
	<keyword>secondary myelodysplastic syndromes</keyword>
	<keyword>disseminated neuroblastoma</keyword>
	<keyword>localized resectable neuroblastoma</keyword>
	<keyword>localized unresectable neuroblastoma</keyword>
	<keyword>recurrent neuroblastoma</keyword>
	<keyword>regional neuroblastoma</keyword>
	<keyword>stage 4S neuroblastoma</keyword>
	<keyword>childhood germ cell tumor</keyword>
	<keyword>recurrent childhood liver cancer</keyword>
	<keyword>localized osteosarcoma</keyword>
	<keyword>metastatic osteosarcoma</keyword>
	<keyword>recurrent osteosarcoma</keyword>
	<keyword>extraocular retinoblastoma</keyword>
	<keyword>intraocular retinoblastoma</keyword>
	<keyword>recurrent retinoblastoma</keyword>
	<keyword>stage I Wilms tumor</keyword>
	<keyword>stage II Wilms tumor</keyword>
	<keyword>stage III Wilms tumor</keyword>
	<keyword>stage IV Wilms tumor</keyword>
	<keyword>stage II childhood liver cancer</keyword>
	<keyword>stage III childhood liver cancer</keyword>
	<keyword>stage IV childhood liver cancer</keyword>
	<keyword>unusual cancers of childhood</keyword>
	<keyword>stage V Wilms tumor</keyword>
	<keyword>childhood myelodysplastic syndromes</keyword>
	<keyword>childhood atypical teratoid/rhabdoid tumor</keyword>
	<keyword>rhabdoid tumor of the kidney</keyword>
	<keyword>childhood extracranial germ cell tumor</keyword>
	<keyword>childhood central nervous system choriocarcinoma</keyword>
	<keyword>childhood central nervous system embryonal tumor</keyword>
	<keyword>recurrent childhood central nervous system embryonal tumor</keyword>
	<keyword>childhood central nervous system germinoma</keyword>
	<keyword>childhood central nervous system mixed germ cell tumor</keyword>
	<keyword>childhood central nervous system teratoma</keyword>
	<keyword>childhood central nervous system yolk sac tumor</keyword>
</DOC>